# RAPP ETFs: 40 Funds That Hold Rapport Therapeutics > 40 thematic and core ETFs hold Rapport Therapeutics (RAPP). SBIO holds the most, at 1.19% of the fund on Aug 31, 2026. Weights and dates for every holder. Data as of Nov 5, 2026. Rebuilt every trading night. ## ETFs that hold Rapport Therapeutics 40 thematic and core ETFs hold Rapport Therapeutics , by holdings dated Jun 30, 2026 to Nov 3, 2026 . SBIO holds the most, at 1.19% of the fund on Aug 31, 2026 . The next largest are IBRN (1.12%) and XPH (1.11%). 1 income and other fund on it is listed below. ### Thematic and core funds that hold it | Fund | Name | Share of the fund | Holdings filed | Asset | | --- | --- | --- | --- | --- | | SBIO | ALPS Medical Breakthroughs ETF | 1.19% | Aug 31, 2026 | Equity | | IBRN | iShares Neuroscience and Healthcare ETF | 1.12% | Nov 3, 2026 | Equity | | XPH | State Street SPDR S&P Pharmaceuticals ETF | 1.11% | Nov 3, 2026 | Equity | | BBC | Virtus Biotech Clinical Trials ETF | 0.71% | Jul 31, 2026 | Equity | | DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.40% | Nov 3, 2026 | Equity | | IHE | iShares U.S. Pharmaceuticals ETF | 0.23% | Nov 3, 2026 | Equity | | TMED | T. Rowe Price Health Care ETF | 0.20% | Jun 30, 2026 | Equity | | IWC | iShares Micro-Cap ETF | 0.19% | Nov 3, 2026 | Equity | | ESSC | Eventide Small Cap ETF | 0.17% | Jul 31, 2026 | Equity | | KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.13% | Jul 31, 2026 | Equity | | VFMO | Vanguard U.S. Momentum Factor ETF | 0.11% | Sep 30, 2026 | Equity | | TNXT | T. Rowe Price Innovation Leaders ETF | 0.11% | Jun 30, 2026 | Equity | | RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.10% | Jul 31, 2026 | Equity | | NUSC | Nuveen ESG Small-Cap ETF | 0.09% | Jul 31, 2026 | Equity | | IBBQ | Invesco Nasdaq Biotechnology ETF | 0.08% | Nov 3, 2026 | Equity | | VTWG | Vanguard Russell 2000 Growth ETF | 0.06% | Sep 30, 2026 | Equity | | AVSC | Avantis U.S. Small Cap Equity ETF | 0.05% | Nov 2, 2026 | Equity | | IBB | iShares Biotechnology ETF | 0.05% | Nov 3, 2026 | Equity | | IWO | iShares Russell 2000 Growth ETF | 0.05% | Nov 3, 2026 | Equity | | RSSL | Global X Russell 2000 ETF | 0.04% | Jul 31, 2026 | Equity | | VTWO | Vanguard Russell 2000 ETF | 0.03% | Sep 30, 2026 | Equity | | IWM | iShares Russell 2000 ETF | 0.03% | Nov 3, 2026 | Equity | | SCHA | Schwab U.S. Small-Cap ETF | 0.03% | Aug 31, 2026 | Equity | | GSSC | GS ActiveBeta U.S. Small Cap Equity ETF | 0.03% | Aug 31, 2026 | Equity | | ISCV | iShares Morningstar Small-Cap Value ETF | 0.03% | Nov 3, 2026 | Equity | | ISCB | | 0.02% | Jul 31, 2026 | Equity | | DFAS | U.S. Small Cap Portfolio: ETF Class Shares | 0.02% | Jul 31, 2026 | Equity | | FHLC | Fidelity MSCI Health Care Index ETF | 0.02% | Jul 31, 2026 | Equity | | VXF | Vanguard Extended Market ETF | 0.01% | Sep 30, 2026 | Equity | | VHT | Vanguard Health Care ETF | 0.01% | Sep 30, 2026 | Equity | | MSML | iShares MSCI USA Small-Cap ETF | 0.01% | Nov 3, 2026 | Equity | | WSML | iShares MSCI World Small-Cap ETF | 0.01% | Nov 3, 2026 | Equity | | MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 0.01% | Aug 31, 2026 | Equity | | ONEQ | Fidelity Nasdaq Composite Index ETF | 0.01% | Aug 31, 2026 | Equity | | VTWV | Vanguard Russell 2000 Value ETF | 0.01% | Sep 30, 2026 | Equity | | IWN | iShares Russell 2000 Value ETF | Rapport Therapeutics (ticker RAPP, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out. Each row shows the date the fund last filed. Look up another company . ### Questions people ask Which ETFs hold Rapport Therapeutics? 40 thematic and core ETFs hold Rapport Therapeutics, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are SBIO at 1.19% of the fund on Aug 31, 2026, IBRN at 1.12% of the fund on Nov 3, 2026 and XPH at 1.11% of the fund on Nov 3, 2026. 1 income and other fund on it is listed apart. --- Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices. Cite: ETFIQ, ETFs holding RAPPORT THERAPEUTICS, data as of Nov 5, 2026. https://etfiq.com/holdings/rapp/ Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms. HTML: https://etfiq.com/holdings/rapp/